EDSA
EDSA clinical trials: Edesa Biotech, Inc.
Every trial on ClinicalTrials.gov where Edesa Biotech, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 3
- As lead sponsor
- 4
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
EDSA on the catalyst calendar · EDSA registry changes
- Primary completion Dec 2027Sponsor estimatePhase 2NCT07889492A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental VitiligoEdesa Biotech Inc. · Non-Segmental Vitiligo (NSV)RecruitingEDSALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 22, 2024ActualPhase 2/Phase 3NCT04401475A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult...Edesa Biotech Inc. · COVID-19TerminatedEDSALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 21, 2022ActualPhase 2NCT03680131Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact DermatitisEdesa Biotech Inc. · Allergic Contact DermatitisCompletedEDSALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2028Sponsor estimatePhase 2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS)RecruitingEDSACollaboratorIFRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2028Sponsor estimatePhase 2NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: VilobelimabPPD Development, LP · Acute Respiratory Distress Syndrome (ARDS)RecruitingEDSACollaboratorIFRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2028Sponsor estimatePhase 2NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: ParidiprubartPPD Development, LP · Acute Respiratory Distress Syndrome (ARDS)RecruitingEDSACollaboratorIFRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2028Sponsor estimatePhase 2NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabPPD Development, LP · Acute Respiratory Distress Syndrome (ARDS)RecruitingEDSACollaboratorIFRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner